巴西首批25万例COVID-19住院患者的特征:全国性数据的回顾性分析
该研究回顾性分析了巴西2020年2月16日至8月15日全国监测数据库中254 288例RT-qPCR确诊COVID-19住院患者(≥20岁)。主要结局为院内死亡率:总体38%(87 515/232 036),ICU患者59%(47 002/79 687),机械通气患者80%(36 046/45 205)。<60岁患者中,东北部死亡率31%(4 204/13 468)高于南部15%(1 694/11 196)。研究提示COVID-19疾病负担广泛,院内死亡率高,即使年轻患者亦不低,且受地区医疗系统差异影响。
要点
- 总体院内死亡率为38%(87 515/232 036),ICU患者为59%(47 002/79 687),机械通气患者为80%(36 046/45 205)。
- <60岁患者院内死亡率东北部为31%(4 204/13 468),南部为15%(1 694/11 196),存在地区差异。
- 东北部16%(1 545/9 960)患者在ICU外接受有创机械通气,南部为8%(431/5 388)。
- 病例数在三个4周时段内增加:19-22周集中在北部、东北部和东南部;27-30周扩散至中西部和南部。
- 254 288例患者中47%(119 657)年龄<60岁,56%(143 521/254 243)为男性,16%(14 979/90 829)无合并症。
适用人群与场景
- 巴西全国≥20岁、RT-qPCR确诊COVID-19并住院、登记于SIVEP-Gripe数据库的患者,研究时段为2020年2月16日至8月15日(流行病学周8-33)。
- 排除:年龄<20岁、未住院或未登记于数据库者(原文未明确其他排除标准)。
诊断标准与关键阈值
- 诊断标准:RT-qPCR确诊COVID-19。
- 纳入标准:年龄≥20岁、住院、登记于SIVEP-Gripe数据库。
- 原文未提及其他评分界值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- ICU患者院内死亡率59%,机械通气患者80%,提示重症患者需积极救治。
- 东北部16%患者在ICU外接受有创机械通气,南部为8%,提示部分地区重症监护资源不足。
- <60岁患者院内死亡率东北部31% vs 南部15%,年轻患者亦需警惕。
研究设计与关键结果
- 研究类型:全国性回顾性分析,样本量254 288例,来自巴西SIVEP-Gripe数据库,覆盖全国五个地区。
- 人群:≥20岁RT-qPCR确诊COVID-19住院患者,平均年龄60岁(SD 17),47%(119 657/254 288)<60岁,56%(143 521/254 243)男性,16%(14 979/90 829)无合并症。
- 主要终点:院内死亡率总体38%(87 515/232 036),ICU患者59%(47 002/79 687),机械通气患者80%(36 046/45 205)。
- 关键次要终点:<60岁患者院内死亡率东北部31%(4 204/13 468)vs 南部15%(1 694/11 196);东北部16%(1 545/9 960)患者在ICU外接受有创机械通气 vs 南部8%(431/5 388)。
- 病例分布:19-22周集中在北部、东北部、东南部;27-30周扩散至中西部和南部。
证据类型、等级与局限
- 证据类型:回顾性全国性队列分析(基于监测数据库)。
- 证据等级:原文未提及。
- 局限:回顾性设计;数据来自监测数据库,可能存在录入不完整;原文未提及其他局限。
对床旁实践的改变
- 提示COVID-19住院患者院内死亡率高,即使<60岁患者亦不低,需重视年轻重症患者的救治。
- 地区间医疗资源分布不均可能影响预后,需关注ICU外有创机械通气等资源紧张情况。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Most low-income and middle-income countries (LMICs) have little or no data integrated into a national surveillance system to identify characteristics or outcomes of COVID-19 hospital admissions and the impact of the COVID-19 pandemic on their national health systems. We aimed to analyse characteristics of patients admitted to hospital with COVID-19 in Brazil, and to examine the impact of COVID-19 on health-care resources and in-hospital mortality.
METHODS: We did a retrospective analysis of all patients aged 20 years or older with quantitative RT-PCR (RT-qPCR)-confirmed COVID-19 who were admitted to hospital and registered in SIVEP-Gripe, a nationwide surveillance database in Brazil, between Feb 16 and Aug 15, 2020 (epidemiological weeks 8-33). We also examined the progression of the COVID-19 pandemic across three 4-week periods within this timeframe (epidemiological weeks 8-12, 19-22, and 27-30). The primary outcome was in-hospital mortality. We compared the regional burden of hospital admissions stratified by age, intensive care unit (ICU) admission, and respiratory support. We analysed data from the whole country and its five regions: North, Northeast, Central-West, Southeast, and South.
FINDINGS: Between Feb 16 and Aug 15, 2020, 254 288 patients with RT-qPCR-confirmed COVID-19 were admitted to hospital and registered in SIVEP-Gripe. The mean age of patients was 60 (SD 17) years, 119 657 (47%) of 254 288 were aged younger than 60 years, 143 521 (56%) of 254 243 were male, and 14 979 (16%) of 90 829 had no comorbidities. Case numbers increased across the three 4-week periods studied: by epidemiological weeks 19-22, cases were concentrated in the North, Northeast, and Southeast; by weeks 27-30, cases had spread to the Central-West and South regions. 232 036 (91%) of 254 288 patients had a defined hospital outcome when the data were exported; in-hospital mortality was 38% (87 515 of 232 036 patients) overall, 59% (47 002 of 79 687) among patients admitted to the ICU, and 80% (36 046 of 45 205) among those who were mechanically ventilated. The overall burden of ICU admissions per ICU beds was more pronounced in the North, Southeast, and Northeast, than in the Central-West and South. In the Northeast, 1545 (16%) of 9960 patients received invasive mechanical ventilation outside the ICU compared with 431 (8%) of 5388 in the South. In-hospital mortality among patients younger than 60 years was 31% (4204 of 13 468) in the Northeast versus 15% (1694 of 11 196) in the South.
INTERPRETATION: We observed a widespread distribution of COVID-19 across all regions in Brazil, resulting in a high overall disease burden. In-hospital mortality was high, even in patients younger than 60 years, and worsened by existing regional disparities within the health system. The COVID-19 pandemic highlights the need to improve access to high-quality care for critically ill patients admitted to hospital with COVID-19, particularly in LMICs.
FUNDING: National Council for Scientific and Technological Development (CNPq), Coordinating Agency for Advanced Training of Graduate Personnel (CAPES), Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ), and Instituto de Salud Carlos III.
参考来源
- Ranzani OT, Bastos LSL, Gelli JGM, et al. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021. PMID: 33460571. doi:10.1016/S2213-2600(20)30560-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。